MOD GRF (1-29) 5 mg + Ipamorelin 5 mg

SIM-20260812-0427Seed 427042712 Aug 2026, 10:47 CST

✓

Preflight complete18 validation rules

⌁

2 componentsIndependent calibrations

225 + 280 nmShared LC run

No PASS labelCriteria not configured

Product overview

Component results

calibration-derivedscenario model

Declared component

Ipamorelin

Identified

Assay4.29 mg85.9% of 5 mg claim

Analyte purity>99.8%analyte related

UV / MS RT5.165 / 5.122Identity ratio 0.997

Spectrum / mass995 / 711Score / g/mol

225 nm composition92.181%reported separately from purity

Declared component

MOD GRF (1-29)

Identified

Assay4.33 mg86.5% of 5 mg claim

Analyte purity99.6%custom peak group

UV / MS RT8.452 / 8.412Identity ratio 0.998

Spectrum / mass991 / 3367Score / g/mol

225 nm composition7.638%reported separately from purity

UHPLC–PDA

Multi-wavelength chromatogram

225 nmShared retention times · channel-specific response

ESI+ full scan · m/z 280–2000

Total ion chromatogram

LC–MS identity

Peak assignment

Target matrix

2 / 2 assigned

Target	UV RT	MS RT	Channel
Ipamorelin	5.165	5.122	280 nm
MOD GRF (1-29)	8.452	8.412	225 nm

No co-elution detectedPeak separation exceeds the configured 0.30 min threshold.

Extracted spectrum & reference

ESI mass spectrum

Extraction RT5.122 min

Base peakm/z 357

Library score995/1000

Mass result711 g/mol

SampleReference

Neutral mass reconstruction

Deconvolution evidence · Ipamorelin

Combined mass711.00 Da+0.43 ppm

Used ion	Assigned charge	Relative intensity	Calculated neutral mass	Mass error	Included
712.0075	z = 1	76%	711.000 Da	0.30 ppm	✓ Yes
356.5076	z = 2	100%	711.001 Da	0.86 ppm	✓ Yes
238.0073	z = 3	76%	711.000 Da	-0.01 ppm	✓ Yes

Immutable audit snapshot

Every result is reproducible from the frozen input and seed.

SHA-256 · 791acb7a10d19345015c2c3028cd18f55b566e862be94598fb132424bef8fc1f